Literature DB >> 23483212

A case of Lamin C gene-mutation with preserved systolic function and ventricular dysrrhythmia.

Kevin Kit Ng1, Gerald Kaye.   

Abstract

Lamin A/C gene-related cardiomyopathy is associated with progressive heart failure and malignant arrhythmias. Current guidelines advise the use of implantable defibrillators to prevent arrhythmogenic sudden cardiac death only in situations where there is evidence of severe left ventricular dysfunction. We describe a case of a woman with genetically confirmed Lamin C deficiency with preserved left ventricular function in whom an implantable defibrillator was inserted and within a month of implantation was used to terminate symptomatic ventricular tachycardia.

Entities:  

Keywords:  Dilated Cardiomyopathy; Lamin A and C deficiency; Sudden Cardiac Death

Year:  2013        PMID: 23483212      PMCID: PMC3593523          DOI: 10.4066/AMJ.2013.1546

Source DB:  PubMed          Journal:  Australas Med J        ISSN: 1836-1935


  10 in total

1.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.

Authors:  Ingrid A W van Rijsingen; Eloisa Arbustini; Perry M Elliott; Jens Mogensen; Johanna F Hermans-van Ast; Anneke J van der Kooi; J Peter van Tintelen; Maarten P van den Berg; Andrea Pilotto; Michele Pasotti; Sharon Jenkins; Camilla Rowland; Uzma Aslam; Arthur A M Wilde; Andreas Perrot; Sabine Pankuweit; Aeilko H Zwinderman; Philippe Charron; Yigal M Pinto
Journal:  J Am Coll Cardiol       Date:  2012-01-31       Impact factor: 24.094

2.  Primary prevention of sudden death in patients with lamin A/C gene mutations.

Authors:  Christophe Meune; Jop H Van Berlo; Frédéric Anselme; Gisèle Bonne; Yigal M Pinto; Denis Duboc
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

3.  ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-25       Impact factor: 29.690

Review 4.  A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

Authors:  Roderick Tung; Peter Zimetbaum; Mark E Josephson
Journal:  J Am Coll Cardiol       Date:  2008-09-30       Impact factor: 24.094

5.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

6.  High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation.

Authors:  H M Bécane; G Bonne; S Varnous; A Muchir; V Ortega; E H Hammouda; J A Urtizberea; T Lavergne; M Fardeau; B Eymard; S Weber; K Schwartz; D Duboc
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

7.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

Authors:  Jop H van Berlo; Willem G de Voogt; Anneke J van der Kooi; J Peter van Tintelen; Gisèle Bonne; Rabah Ben Yaou; Denis Duboc; Tom Rossenbacker; Hein Heidbüchel; Marianne de Visser; Harry J G M Crijns; Yigal M Pinto
Journal:  J Mol Med (Berl)       Date:  2004-11-13       Impact factor: 4.599

8.  Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

Authors:  Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Amanda Peterson; Duanxiang Li; Petra Jakobs; Michael Litt; Charles B Porter; Peter S Rahko; Ray E Hershberger
Journal:  Am Heart J       Date:  2008-03-12       Impact factor: 4.749

9.  Long-term outcome and risk stratification in dilated cardiolaminopathies.

Authors:  Michele Pasotti; Catherine Klersy; Andrea Pilotto; Nicola Marziliano; Claudio Rapezzi; Alessandra Serio; Savina Mannarino; Fabiana Gambarin; Valentina Favalli; Maurizia Grasso; Manuela Agozzino; Carlo Campana; Antonello Gavazzi; Oreste Febo; Massimiliano Marini; Maurizio Landolina; Andrea Mortara; Giovanni Piccolo; Mario Viganò; Luigi Tavazzi; Eloisa Arbustini
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

Review 10.  The proarrhythmic potential of implantable cardioverter-defibrillators.

Authors:  S L Pinski; G J Fahy
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

  10 in total
  3 in total

1.  Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.

Authors:  Nivedita Patni; Chao Xing; Anil K Agarwal; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2017-07-07       Impact factor: 2.802

2.  Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.

Authors:  Antonio Atalaia; Rabah Ben Yaou; Karim Wahbi; Annachiara De Sandre-Giovannoli; Corinne Vigouroux; Gisèle Bonne
Journal:  J Neuromuscul Dis       Date:  2021

3.  The Emerging Role of Lamin C as an Important LMNA Isoform in Mechanophenotype.

Authors:  Rafael D González-Cruz; Kris N Dahl; Eric M Darling
Journal:  Front Cell Dev Biol       Date:  2018-11-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.